JP2020505403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505403A5 JP2020505403A5 JP2019540384A JP2019540384A JP2020505403A5 JP 2020505403 A5 JP2020505403 A5 JP 2020505403A5 JP 2019540384 A JP2019540384 A JP 2019540384A JP 2019540384 A JP2019540384 A JP 2019540384A JP 2020505403 A5 JP2020505403 A5 JP 2020505403A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- motomeko
- composition
- cells
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022184788A JP7509504B2 (ja) | 2017-01-27 | 2022-11-18 | 免疫療法のためのコア／シェル構造プラットホーム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762451575P | 2017-01-27 | 2017-01-27 | |
| US62/451,575 | 2017-01-27 | ||
| PCT/US2018/015601 WO2018140826A1 (en) | 2017-01-27 | 2018-01-26 | Core/shell structure platform for immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184788A Division JP7509504B2 (ja) | 2017-01-27 | 2022-11-18 | 免疫療法のためのコア／シェル構造プラットホーム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505403A JP2020505403A (ja) | 2020-02-20 |
| JP2020505403A5 true JP2020505403A5 (https=) | 2021-03-11 |
| JP7181880B2 JP7181880B2 (ja) | 2022-12-01 |
Family
ID=61899339
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019540384A Active JP7181880B2 (ja) | 2017-01-27 | 2018-01-26 | 免疫療法のためのコア／シェル構造プラットホーム |
| JP2022184788A Active JP7509504B2 (ja) | 2017-01-27 | 2022-11-18 | 免疫療法のためのコア／シェル構造プラットホーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184788A Active JP7509504B2 (ja) | 2017-01-27 | 2022-11-18 | 免疫療法のためのコア／シェル構造プラットホーム |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11382964B2 (https=) |
| EP (3) | EP3573656B1 (https=) |
| JP (2) | JP7181880B2 (https=) |
| KR (2) | KR102627347B1 (https=) |
| CN (2) | CN109152830B (https=) |
| AU (1) | AU2018212887B2 (https=) |
| CA (1) | CA3051136A1 (https=) |
| DK (2) | DK4008344T5 (https=) |
| ES (2) | ES2973040T3 (https=) |
| SG (1) | SG11201906744VA (https=) |
| WO (1) | WO2018140826A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011106702A2 (en) | 2010-02-25 | 2011-09-01 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
| PL4023249T3 (pl) | 2014-04-23 | 2025-03-10 | Modernatx, Inc. | Szczepionki z kwasem nukleinowym |
| AU2016341309A1 (en) | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Cancer vaccines |
| CN109152830B (zh) | 2017-01-27 | 2023-11-03 | 卫理公会医院 | 用于免疫疗法的核/壳结构平台 |
| CA3063932A1 (en) * | 2017-05-18 | 2018-11-12 | The Regents Of The University Of California | Nano-enabled immunotherapy in cancer |
| US11433143B2 (en) | 2017-05-18 | 2022-09-06 | The Regents Of The University Of California | Nano-enabled immunotherapy in cancer |
| WO2020037102A1 (en) * | 2018-08-15 | 2020-02-20 | University Of Florida Research Foundation, Inc. | Methods of sensitizing tumors to treatment with immune checkpoint inhibitors |
| MA54192A (fr) * | 2018-11-07 | 2021-09-15 | Modernatx Inc | Vaccins à arn contre le cancer |
| CN109260157A (zh) * | 2018-11-19 | 2019-01-25 | 上海交通大学 | 一种正电荷多肽脂质体纳米制剂及其制备方法与应用 |
| CA3126544A1 (en) * | 2019-01-12 | 2020-07-16 | The Methodist Hospital | Self-assembled peptide nanoparticle and use thereof |
| KR20210151822A (ko) * | 2019-03-14 | 2021-12-14 | 엔진 인코포레이티드 | 키토산-핵산 나노입자의 가역성 코팅 및 이의 사용 방법 |
| US12496279B2 (en) | 2019-04-11 | 2025-12-16 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| EP3983077A4 (en) * | 2019-06-17 | 2023-12-20 | Alnylam Pharmaceuticals, Inc. | DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM |
| CN114502204A (zh) * | 2019-08-14 | 2022-05-13 | 库尔维科公司 | 具有降低的免疫刺激性质的rna组合和组合物 |
| DE102019122014A1 (de) * | 2019-08-15 | 2021-02-18 | Technische Universität Darmstadt | Reduktion der Knochenresorption, insbesondere bei chronischen Gelenkerkrankungen |
| WO2021081043A1 (en) * | 2019-10-22 | 2021-04-29 | The Johns Hopkins University | Mucus penetrating particle compositions and methods of use thereof enhancing immune response |
| KR102579284B1 (ko) * | 2020-09-22 | 2023-09-18 | 비피진 주식회사 | 신규의 cd47 바인더와 폴리뉴클레오티드를 포함하는 암 치료를 위한 리포좀 복합체 |
| CN112245575B (zh) * | 2020-10-26 | 2024-07-26 | 上海杏禾医疗科技有限公司 | 含支化聚合物和mRNA的核壳结构的抗肿瘤疫苗及其用途 |
| WO2023034957A1 (en) * | 2021-09-03 | 2023-03-09 | University Of Connecticut | Stabilization of antigens for long term administration in transdermal microneedle patches |
| CN114699420A (zh) * | 2022-03-08 | 2022-07-05 | 南方科技大学 | 一种用于治疗前列腺癌组合物及其制备方法与应用 |
| CN114699538A (zh) * | 2022-04-02 | 2022-07-05 | 中国药科大学 | 一种核-壳式高效基因药物递送系统及其制备方法 |
| BE1031668B1 (fr) * | 2023-06-02 | 2025-01-16 | Inhatarget Therapeutics | Composition pharmaceutique pour inhalation |
| BE1031669B1 (fr) * | 2023-06-02 | 2025-01-14 | Inhatarget Therapeutics | Composition pharmaceutique pour inhalation |
| CN117045809B (zh) * | 2023-09-27 | 2025-08-29 | 国家纳米科学中心 | 异种哺乳动物细胞来源的囊泡在制备疫苗载体中的应用 |
| KR20250063352A (ko) * | 2023-11-01 | 2025-05-08 | 가톨릭대학교 산학협력단 | mRNA가 봉입된 이중 나노입자, 이의 제조방법 및 이의 약학적 용도 |
| CN117442552B (zh) * | 2023-11-20 | 2024-03-26 | 山东大学 | 一种淋巴结内t细胞区靶向纳米粒及其水凝胶 |
| CN117883410A (zh) * | 2024-01-22 | 2024-04-16 | 华中科技大学同济医学院附属协和医院 | 包封有mRNA及Acod1基因si-RNA的脂质体纳米颗粒及其应用 |
| CN118001254B (zh) | 2024-04-09 | 2024-07-26 | 北京悦康科创医药科技股份有限公司 | 靶向抗原呈递细胞的脂质组合物及其应用 |
| DE102024112307A1 (de) * | 2024-05-02 | 2025-11-06 | INM - Leibniz-Institut für Neue Materialien gemeinnützige Gesellschaft mit beschränkter Haftung | Kompositpartikel |
| CN119040262B (zh) * | 2024-08-22 | 2025-11-18 | 北京理工大学 | 一种呈递肿瘤抗原并高度激活t细胞的外泌体通用制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| WO2010037408A1 (en) * | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| EP2765997A4 (en) * | 2011-10-14 | 2015-06-24 | Stc Unm | POROUS NANOPARTICLE-SUPPORTED LIPID DOUBLE LAYERS (PROTOCOLS) FOR THE TARGETED RELEASE BY TRANSDERMAL RELEASE AND USE METHOD THEREFOR |
| CN103181896B (zh) * | 2011-12-30 | 2015-10-14 | 沈阳药科大学 | 一种含有小檗胺类药物的脂质体制剂及其制备方法 |
| RS57739B1 (sr) * | 2013-03-14 | 2018-12-31 | Translate Bio Inc | Kompozicije cftr irnk i postupci i upotrebe u vezi sa njima |
| CN103550783A (zh) * | 2013-04-27 | 2014-02-05 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种核酸类药物靶向递送系统及其制备方法 |
| JP6620093B2 (ja) * | 2013-07-23 | 2019-12-11 | アービュートゥス バイオファーマ コーポレイションＡｒｂｕｔｕｓ Ｂｉｏｐｈａｒｍａ Ｃｏｒｐｏｒａｔｉｏｎ | メッセンジャーｒｎａを送達するための組成物及び方法 |
| AU2014340149B2 (en) * | 2013-10-22 | 2020-12-24 | Shire Human Genetic Therapies, Inc. | CNS delivery of mRNA and uses thereof |
| HK1250012A1 (zh) * | 2015-04-02 | 2018-11-23 | The Methodist Hospital System | 基於多孔硅微粒的癌症疫苗及增强抗肿瘤免疫的方法 |
| CN109152830B (zh) | 2017-01-27 | 2023-11-03 | 卫理公会医院 | 用于免疫疗法的核/壳结构平台 |
| KR102579284B1 (ko) * | 2020-09-22 | 2023-09-18 | 비피진 주식회사 | 신규의 cd47 바인더와 폴리뉴클레오티드를 포함하는 암 치료를 위한 리포좀 복합체 |
-
2018
- 2018-01-26 CN CN201880001680.5A patent/CN109152830B/zh active Active
- 2018-01-26 ES ES21210308T patent/ES2973040T3/es active Active
- 2018-01-26 CA CA3051136A patent/CA3051136A1/en active Pending
- 2018-01-26 EP EP18715827.4A patent/EP3573656B1/en active Active
- 2018-01-26 AU AU2018212887A patent/AU2018212887B2/en active Active
- 2018-01-26 EP EP21210308.9A patent/EP4008344B1/en active Active
- 2018-01-26 CN CN202310076857.0A patent/CN115845040A/zh active Pending
- 2018-01-26 US US15/881,637 patent/US11382964B2/en active Active
- 2018-01-26 ES ES18715827T patent/ES2905591T3/es active Active
- 2018-01-26 WO PCT/US2018/015601 patent/WO2018140826A1/en not_active Ceased
- 2018-01-26 JP JP2019540384A patent/JP7181880B2/ja active Active
- 2018-01-26 DK DK21210308.9T patent/DK4008344T5/da active
- 2018-01-26 SG SG11201906744VA patent/SG11201906744VA/en unknown
- 2018-01-26 KR KR1020197024702A patent/KR102627347B1/ko active Active
- 2018-01-26 DK DK18715827.4T patent/DK3573656T3/da active
- 2018-01-26 KR KR1020247001662A patent/KR20240014586A/ko active Pending
- 2018-01-26 EP EP23214393.3A patent/EP4309739B1/en active Active
-
2022
- 2022-05-24 US US17/751,812 patent/US12533415B2/en active Active
- 2022-11-18 JP JP2022184788A patent/JP7509504B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505403A5 (https=) | ||
| US12496345B2 (en) | Method of treating cancer | |
| JP2024133065A (ja) | メッセンジャーリボ核酸薬物の治療投与のための方法 | |
| US20200276230A1 (en) | Particles for the treatment of cancer in combination with radiotherapy | |
| JP6240600B2 (ja) | ヒト化免疫モノクローナル抗体の変異体 | |
| US11433136B2 (en) | Polyacetal polymers, conjugates, particles and uses thereof | |
| WO2021098621A1 (zh) | 一种包载免疫佐剂纳米颗粒及应用 | |
| JP2023014340A (ja) | ポリマーナノ粒子 | |
| CN107137717A (zh) | 一种携载抗肿瘤药物连接cd22单抗靶向淋巴瘤的血小板靶向载药体系的制备方法 | |
| US20210330696A1 (en) | A high capacity platform for immunogenic cancer cell death | |
| EP4243778A1 (en) | Nanoparticle complex with defined sizes | |
| JP5843086B2 (ja) | 治療活性物質の作用を増強するための高分子化環状ニトロキシドラジカル化合物の使用 | |
| EP4031180A1 (en) | Methods for triggering m1 macrophage polarization | |
| US20230381349A1 (en) | Methods and compositions for imaging and treating cancer | |
| WO2021239730A1 (en) | Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof | |
| Rajalakshmi et al. | Nanomedicine for cancer therapy: current status and challenges | |
| JP6987271B2 (ja) | 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途 | |
| Wang et al. | A Carrier-free Peptide Co-assembled System with Synergistic Antitumor Effect Combines Immunotherapy and Sonodynamic Therapy | |
| NL2027601B1 (en) | Target mediated endocytotic drug delivery | |
| NL2026569B1 (en) | Target mediated endocytotic drug delivery | |
| Rengan | 9 Nanomedicine for Cancer Therapy | |
| CN117695242A (zh) | 环二核苷酸自组装纳米粒子及其制备和应用 | |
| Dong et al. | Noninvasive ultrasound targeted modulation of calcium influx in splenic immunocytes potentiates antineoplastic immunity attenuating hepatocellular carcinoma proliferation | |
| WO2025031498A1 (zh) | Toll样受体激动剂及其应用 | |
| WO2024236048A1 (en) | Combination therapy for treating tumors with radiotherapy |